
Please try another search
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company’s lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer’s disease; and NVG-300, which is in a preclinical model of ischemic stroke and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
Krista L. McKerracher | - | 2021 | Independent Director |
Harold Martin Punnett | - | 2017 | Co-Founder & Independent Director |
George Perry | 72 | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Jeremy Chataway | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Michael A. Weiner | 78 | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Brian Kwon | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Robert W. Naismith | 80 | 2021 | Multiple Sclerosis Clinical Advisory Board |
Randall E. Kaye | 63 | 2020 | Chief Medical Advisor & Director |
Jeffrey K. Cohen | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Brian McAlister | - | - | Co-Founder & Advisor |
Jack Antel | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
James Guest | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Jerry Silver | - | - | Co-Inventor & Scientific Advisor |
Bruce T. Lamb | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Daniel P. Lammertse | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Adam H. Rogers | - | 2022 | Chairman & Interim CEO |
Brian Eric Bayley | 72 | 2018 | Independent Director |
Henrik Zetterberg | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Martin Rhys Farlow | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Jeffrey L. Cummings | 76 | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Steven Kirshblum | - | 2021 | Member of Clinical Spinal Cord Injury Advisory Board |
Michael Davis | - | 2020 | Advisor |
Linda Jones | - | - | Member of Clinical Spinal Cord Injury Advisory Board |
John Craig Thompson | - | 2022 | Independent Director |
Anneke Van Der Walt | - | 2021 | Multiple Sclerosis Clinical Advisory Board |
Reisa Sperling | - | 2021 | Member of Alzheimer's Disease Scientific Advisory Board |
Gianni Ruffolo | - | 2023 | Independent Director |
Neil A. Klompas | 53 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review